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Ethanolic and ethyl acetate extracts of Cussonia spica-
ta, C. paniculata and Schefflera umbellifera were
screened for anti-bacterial, anti-malarial and anti-inflam-
matory activities. Root and bark extracts of C. spicata
showed anti-bacterial activity against Staphylococcus
aureus in the disc-diffusion assay. All species inhibited
cyclooxygenase in the cyclooxygenase-1 assay. S.
umbellifera ethanolic and ethyl acetate extracts inhibit-
ed Plasmodium falciparum, a malaria-causing agent, in
an in vitro assay. The results obtained rationalised the
use of the three selected species of Araliaceae for spe-
cific types of diseases in traditional medicine.
Introduction
The use of species of the family Araliaceae (Cussonia and
Schefflera) in traditional medicine against infections, inflam-
mation and malaria is well known (Table 1). Preparations of
specific plant parts are used for treating particular ailments.
However, of interest is the rationale for the use of certain
species to treat specific ailments. Therefore, there is a need
to validate whether the preparations from specific plant parts
to treat specific diseases are utilised because of availability
or whether they confer a favourable result as postulated by
some traditional healers. It is estimated that 80% of Zulu
patients consult traditional healers (Gumede 1989).
Consequently, in this paper, Cussonia and Schefflera
species were tested for anti-bacterial, anti-inflammatory and
anti-malarial activity, as a first step in validating their use in
traditional medicine by in vitro bioassays.
Material and Methods
Collection and preparation of plant material
The leaves, bark, stem and roots of Cussonia spicata and C.
paniculata were collected from the University of Natal
Botanical Garden, Pietermaritzburg. Plants were identified
by the Herbarium of the University of Natal,
Pietermaritzburg. Leaves and bark of Schefflera umbellifera
(=Cussonia umbellifera) were collected from KwaZulu-Natal
Nature Conservation Services, Pietermaritzburg. The plant
material was collected and dried at 50°C. Dry material was
ground into fine powders and stored in airtight containers at
room temperature in the dark.
Preparation of plant extracts
Each extract was prepared by extracting 2g powdered plant
material with 20ml of water, ethanol or ethyl acetate for
30min in an ultrasound bath. The extraction mixtures were
centrifuged or filtered, the supernatants decanted and then
air-dried. The residues were resuspended in water, ethanol
or ethyl acetate, respectively, to an assay-specific concen-
tration. Dry extract residues were otherwise stored at room
temperature until required. Plant extracts were screened
using the assays outlined below. 
Disc diffusion assay
Leaf, bark, stem and root extracts of C. spicata and C. pan-
iculata were tested for anti-bacterial activity using the disc
diffusion assay (Rasoanaivo and Ratsimamanga-Urverg
1993). Only leaf and bark extracts of Schefflera umbellifera
were screened for anti-bacterial activity as stem and roots
were not available. Seven strains of bacteria, Bacillus sub-
tilis, Escherichia coli, Klebsiella pneumoniae, Micrococcus
luteus, Pseudomonas aeruginosa, Staphylococcus aureus
and Staphylococcus epidermidis were maintained on
Mueller-Hinton (MH) nutrient agar at 4°C. Molton MH agar
(10ml) was inoculated with a broth culture (1ml, containing
106 B 108 bacteria/ml) of the respective bacterial strains and
poured over base plates containing 10ml MH agar in sterile
9cm Petri dishes. Ten microlitres (1mg) of plant extract were
applied to a sterile filter paper disc (Whatman No. 3, 6mm in
diameter). The discs were allowed to dry before being
placed onto the seeded top layer of the agar plates. Each
plate contained four paper discs with plant extract and a disc
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with a neomycin control (2’Og). Each extract was tested in
quadruplicate. The plates were incubated at 37°C for 12h,
whereafter inhibition zones were recorded.
Anti-malarial assay
Bark extracts of C. spicata, C. paniculata and S. umbellifera
were tested for anti-malarial activity. Only the bark extracts
were tested because preparations of these are used for this
purpose in traditional medicine. The extracts were tested at
50, 100 and 200mg ml-1. The South African isolate (PfUP1)
of the malaria parasite Plasmodium falciparum was used in
the bioassays. For continuous in vitro culturing, a slightly
modified version of the Trager and Jensen method was
employed (Trager and Jensen 1976, Hoppe 1993).
The wash medium consisted of 10.4gRPMI 1640 L-gluta-
mine, 5.94g HEPES buffer, 4.0g D-glucose, 44mg hypoxan-
thine, 5% sodium hydrogen carbonate and 4mg of gen-
tamycin dissolved in 900ml deionised sterile water. For use
as culture medium, this wash medium was supplemented
with 10% human serum of a positive blood group after heat
inactivation at 56°C for 20min. The parasite culture was then
suspended in 10ml of this culture medium in a 75ml culture
flask (Sterilin). The culture, consisting of parasites and cul-
ture medium, was further supplemented with fresh, uninfect-
ed human erythrocytes with an O+ blood group.
To determine the activity of extracts against P. falciparum
in an accurate in vitro assay, a slightly modified version of
the parasite lactate dehydrogenase assay was used (Makler
et al. 1993). The experiment was done in triplicate with 1%
parasitemia and 5% hematocrit and incubated at 37°C for
48h in 96-well, flat bottomed microtiter plates in 5% O2, 5%
CO2, 90% N2. After 48h, a duplicate plate was prepared with
100μl Malstat Ô reagent [133ml Triton X-100, 1.33g lactate,
0.44g TRIS buffer and 44mg 3-acetylpyrimidine adenine din-
ucleotide (APAD)]. This solution was made up to 200ml in
distilled water and added to each plate together with 25μl
developing dye solution [160mg Nitroblue tetrazolium (NBT)
and 8mg phenazine ethosulphate (PES) to 100ml Millipore
water] and 10ml from the incubated plate. The duplicate
plate was incubated for 20min in the dark and read with an
ELISA plate reader at 620nm.
Cyclooxygenase (COX-1) assay 
A modified procedure of the White and Glassman (1974)
method was used to screen for prostaglandin-synthesis
inhibitory activity (Jäger et al. 1996).
Results and Discussion
Anti-bacterial activity
After overnight incubation at 37°C, a clear inhibition zone
was visible around the neomycin paper discs and some of
the plant extract discs. Table 2 shows the ratio of the inhibi-
tion zone of the C. spicata extracts (50mg ml-1) to the inhibi-
tion zone of the reference, neomycin (200mg ml-1) against
the test bacteria. Generally, water extracts did not show anti-
bacterial activity, especially bark extracts. Ethanol and ethyl
acetate root extracts showed the highest inhibition ratio
(0.50) against Staphylococcus aureus. Of the three species
screened for anti-bacterial activity only C. spicata showed
significant activity. This result validates the use of C. spicata
in traditional medicine. The root and bark decoction of this
species is used in southern Africa as a treatment for gonor-
rhea and other venereal diseases. C. spicata is easily
accessible to traditional people because it is the most abun-
dant species of the genus in southern Africa. There is limit-
ed information available about the dosages administered to
sick patients by traditional healers. However, the degree of
activity displayed by bark and root extracts does not suggest
great amounts of active compounds present from these
sources. Because of low activity, there is however less
chance of toxicity.
Anti-malarial activity
Table 3 represents the percentage inhibition against a
chloroquine resistant strain of Plasmodium falciparum. Not
much activity was found with C. spicata and C. paniculata
bark extracts. However, S. umbellifera showed a high
inhibitory activity (100%) with the ethanol and ethyl acetate
bark extracts at a concentration of 200mg ml-1. Even at lower
concentrations of 50mg ml-1, ethanol and ethyl acetate bark
Table 1: Traditional medicinal uses of Cussonia and Schefflera species (Watt and Breyer-Brandwijk 1962, Hutchings et al. 1996)
Species Plant Part Used Preparation Ailment Treated
C. arborea Hochst. ex A. Rich. Root Emenagogue –
C. paniculata Eckl. & Zeyh. Leaf Decoction (boiled) Early nervous and mental disease
C. paniculata Eckl. & Zeyh. – Enema Colic, dysmenorrhoea
C. spicata Thunb. Bark Warmed Relieve cramps, stomach ulcers
C. spicata Thunb. Stem, Root Decoction Dysmenorrhoea
C. spicata Thunb. Bark, Root – Gonorrhea and other venereal diseases
C. spicata Thunb. Leaves – Indigestion
C. spicata Thunb. Root Powder Emetic in biliousness
C. spicata Thunb. Root Infusion Malaria
S. umbellifera (Sond.) Baill. Bark – Malaria
S. umbellifera (Sond.) Baill. Leaves – Rheumatism, colic and insanity
– = Plant part, preparation or ailment not specified in literature
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extracts of S. umbellifera showed inhibition of 45 and 55%,
respectively. Literature shows that both C. spicata and S.
umbellifera are used traditionally to treat malaria (Table 1).
Traditionally, roots of C. spicata and the bark of S. umbellif-
era are used.
Anti-inflammatory activity
C. spicata showed less anti-inflammatory activity than C.
paniculata and S. umbellifera in the COX-1 assay (Table 4).
Generally, ethanol and ethyl acetate extracts were more
active than water extracts. In the COX-1 assay indomethacin
(5mM in final assay vol), the standard, inhibited cyclooxyge-
nase to a level of 78%. Although C. paniculata showed inhi-
bition against cyclooxygenase, the highest activity was dis-
played by S. umbellifera leaf and bark extracts (Table 4).
Both C. paniculata and S. umbellifera are used for treatment
of diseases associated with prostaglandin synthesis such as
rheumatism, dysmenorrhoea, colic, as well as diseases
associated with the nervous system (Watt and Breyer-
Brandwijk 1962, Hutchings et al. 1996). Customarily, a
decoction of the leaves is widely used to treat these dis-
eases (Watt and Breyer-Brandwijk, 1962). However, the
screening of other plant parts showed that the bark and stem
extracts of C. paniculata were also active.
C. spicata is also used for treating diseases associated
with inflammation such as dysmenorrhoea, stomach cramps
and stomach ulcers (Hutchings et al. 1996). Some C. panic-
ulata and C. spicata bark extracts gave a negative result in
the COX-1 assay. Jäger et al. (1996) suggested that a neg-
ative result in the COX-1 assay does not imply that the plant
is necessarily without anti-inflammatory activity. The active
compound(s) could work at other sites in the complex
process of inflammation.
According to recorded literature (Table 1), all three
species are used by traditional healers to cure diseases that
are caused by the complex process of inflammation.
Therefore, it can be speculated that two factors, availability
and efficacy, affect the choice of species. Availability
becomes a problem when traditional healers have harvest-
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Bacterial Strain Gram Status (- or +) Plant Part Analysed Extracts
Water Ethanol Ethyl Acetate
E. coli - Bark 0.00 0.15 0.20
Root 0.06 0.00 0.00
P. aeruginosa - Bark 0.00 0.09 0.13
Root 0.00 0.10 0.15
K. pneumoniae - Bark 0.00 0.20 0.10
Root 0.19 0.14 0.19
M. luteus + Bark 0.00 0.27 0.09
Root 0.25 0.10 0.14
B. subtilis + Bark 0.20 0.09 0.09
Root 0.18 0.05 0.00
S. aureus + Bark 0.00 0.10 0.22
Root 0.09 0.50 0.50
S. epidermidis + Bark 0.00 0.00 0.02
Root 0.12 0.24 0.44
Table 2: Anti-bacterial screening of Cussonia spicata. Anti-bacterial activity is expressed as the ratio of the inhibition zone (mm) produced
around the extract to the inhibition zone around the reference neomycin control
Species Extract Inhibition (%)
Concentration (μg ml-1)
50 100 200
C. paniculata Water – – 10
Ethanol – – 30
Ethyl acetate – – 20
C. spicata Water – – 20
Ethanol – – 35
Ethyl acetate – – –
S. umbellifera Water – – –
Ethanol 45 80 100
Ethyl acetate 55 90 100
Chloroquine IC50 = 150ng ml-1, – = indicates no activity
Table 3: Percentage inhibition of Plasmodium falciparum by bark
extracts from Cussonia and Schefflera species
Species Plant Part
Analysed Inhibition (%)
Water Ethanol Ethyl Acetate
C. paniculata Leaves 29 80 58
Bark 0 42 78
Stem 27 85 80
Roots 32 15 38
C. spicata Leaves 15 56 13
Bark 35 0 0
Stem 51 19 35
Roots 35 27 38
S. umbellifera Leaves 39 92 80
Bark 19 93 92
Plant extracts were tested at 0.2μg μl-1 in the final assay volume.
Indomethacin at 5μM in the final assay volume gave an inhibition of
78%
Table 4: Percentage cyclooxygenase-inhibition of extracts from
Cussonia and Schefflera species
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ed and depleted what was easily available to them.
Alternatively, they are bound to travel long distances to
obtain plant material they need. Additionally, patients could
also influence traditional healers by demanding medicines
known to work best for healing a particular illness.
The results obtained from screening of the three species
suggest that the healers have selected the species for suc-
cessful treatment of various diseases. Further work that
could possibly emerge from this is isolation of active com-
pounds, especially from C. paniculata and S. umbellifera.
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